Tuesday, May 5, 2026

North Korea’s ‘Southern Border Line’ Push Shakes Armistice Framework, Raises Need for New Coexistence Approach

North Korea's shift to define the MDL as a "southern border line" poses threats but also opportunities for new coexistence strategies.

ChatGPT Just Went Pro: New Features, 3M Paid Users, and Total Integration

OpenAI introduces new features for ChatGPT, enhancing connectivity for premium users and exploring custom AI data access tools.

JW Pharmaceuticals Secures Exclusive Rights for Innovative GLP-1 Drug Vopaglutide in South Korea

JW Pharmaceutical secures exclusive rights for Vopaglutide, a promising treatment for diabetes and obesity, with significant milestone payments.

Tag: SillaJen

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

SillaJen’s Breakthrough Cancer BAL0891 Drug Set for ASCO 2026 Reveal

SillaJen's anticancer drug BAL0891 will be presented at the ASCO Annual Meeting, currently in Phase 1 trials for solid tumors and AML.

Breakthrough Cancer Drug BAL0891: Key Findings to be Revealed at AACR 2026

SillaJen's cancer drug BAL0891 will be presented at the AACR 2026 conference, highlighting its effects on gastric and breast cancer models.

Revolutionary Cancer Treatment SJ-650: What Makes It a Game Changer in Oncology?

SillaJen's SJ-650 cancer treatment platform gains recognition with publication in Molecular Therapy, showcasing its innovative approach and efficacy.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.